Philippines’ Department of Science and Technology Introduces 6 Virus and Vaccine-focused R&D Projects

Jun 2021

The Department of Science and Technology (DOST) has approved the conduct of six flagship R&D projects that will serve as foundation studies of the proposed Virology and Vaccine Institute of the Philippines. The DOST has allocated PHP 284 million (USD 5.83 million) for the R&D programs.

The 6 R&D studies identified by the DOST are:

  1. The isolation and purification of the Philippines common viruses with medical importance and pandemic potential for Antigen-Antibody Studies – this would focus on isolating pure cultures of coronaviruses, and avian viruses, from civet cats, and chickens.
  2. Combination Therapy: Lytic Bacteriophages and Plant Extracts against Multidrug-resistant bacteria – this will isolate and characterize bacteriophages from the environment and screen them for their bactericidal and antibiofilm activities against multidrug-resistant (MDR) bacteria.
  3. Detection of Food and Water-borne Bacterial Pathogens using Phage-based Diagnostics – optical density measurements will be investigated as a simple and inexpensive method for the detection and quantification of bacteriophages at different levels of sensitivity and time efficiency.
  4. The De Novo Synthesis of a Non-Infective Zika Virus-like Particles: Initial Development of a Template for Zika-related Diagnostics – the study would aim to produce non-infective, virus-like particles (VLPs) or pseudoviruses of Zika Virus (ZikV), via de novo synthesis.
  5. Antigenic Peptides as Potential Candidates for COVID-19 Vaccines; and
  6. Study on the Development of Antibody Test Kits for COVID-19 Using Enzyme Immuno-assay.

The first 4 R&D projects will be implemented by the DOST-Industrial Technology Development Institute, while leading the vaccine-focused research are Saint Luke’s Medical Center for the 5th R&D project and the Research Institute for Tropical Medicine (RITM) of the Department of Health (DOH) for the 6th R&D project.

The scarcity of Covid-19 testing kits and shortage in vaccine supplies were the main drivers for the proposed establishment of the Virology and Vaccine Institute which is still currently being deliberated by Congress.

(Source: Philippine News Agency)

About Us

Orissa International helps companies that want to develop a market entry strategy for Southeast Asia or implement their business expansion into the region. We have very strong domain knowledge of markets and industry sectors, and a business network of over 16,000 companies that includes distributors, resellers, system integrators and local manufacturers, that we have built through advising and guiding more than 5,000 companies with their market expansion into the ASEAN region over the last 25 years.

Orissa International is headquartered in Singapore, with additional offices in Malaysia, Indonesia, Thailand, Vietnam, and the Philippines.

Our Services